Nucleic Acid Isolation And Purification Market Size, Share & Trends Report

Nucleic Acid Isolation And Purification Market Size, Share & Trends Analysis Report By Product, By Type, By Application, By Method, By End-use, By Region, And Segment Forecasts, 2024 - 2030

  • Report ID: GVR-2-68038-580-9
  • Number of Pages: 135
  • Format: Electronic (PDF)
  • Historical Range: 2018 - 2022
  • Industry: Healthcare

Research Methodology

A three-pronged approach was followed for deducing the nucleic acid isolation and purification market estimates and forecasts. The process has three steps: information procurement, analysis, and validation. The whole process is cyclical, and steps repeat until the estimates are validated. The three steps are explained in detail below:

Information procurement: Information procurement is one of the most extensive and important stages in our research process, and quality data is critical for accurate analysis. We followed a multi-channel data collection process for nucleic acid isolation and purification market to gather the most reliable and current information possible.

  • We buy access to paid databases such as Hoover’s and Factiva for company financials, industry information, white papers, industry journals, SME journals, and more.
  • We tap into Grand View’s proprietary database of data points and insights from active and archived monitoring and reporting.
  • We conduct primary research with industry experts through questionnaires and one-on-one phone interviews.
  • We pull from reliable secondary sources such as white papers and government statistics, published by organizations like WHO, NGOs, World Bank, etc., Key Opinion Leaders (KoL) publications, company filings, investor documents, and more.
  • We purchase and review investor analyst reports, broker reports, academic commentary, government quotes, and wealth management publications for insightful third-party perspectives.

Analysis: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilized different methods of nucleic acid isolation and purification market data depending on the type of information we’re trying to uncover in our research.

  • Market Research Efforts: Bottom-up Approach for estimating and forecasting demand size and opportunity, top-down Approach for new product forecasting and penetration, and combined approach of both Bottom-up and Top-down for full coverage analysis.

  • Value-Chain-Based Sizing & Forecasting: Supply-side estimates for understanding potential revenue through competitive benchmarking, forecasting, and penetration modeling.

  • Demand-side estimates for identifying parent and ancillary markets, segment modeling, and heuristic forecasting.

  • Qualitative Functional Deployment (QFD) Modelling for market share assessment.

Market formulation and validation: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilize different methods of data analysis depending on the type of information we’re trying to uncover in our research.

  • Market Formulation: This step involves the finalization of market numbers. This step on an internal level is designed to manage outputs from the Data Analysis step.

  • Data Normalization: The final market estimates and forecasts are then aligned and sent to industry experts, in-panel quality control managers for validation.

  • This step also entails the finalization of the report scope and data representation pattern.

  • Validation: The process entails multiple levels of validation. All these steps run in parallel, and the study is forwarded for publishing only if all three levels render validated results.

Nucleic Acid Isolation And Purification Market Categorization:

The nucleic acid isolation and purification market was categorized into six segments, namely product (Kits & Reagents, Instruments), type (DNA Isolation & Purification, RNA Isolation & Purification), method (Column Based, Magnetic Beads, Reagent Based), application (Precision Medicine, Diagnostics, Drug Discovery & Development, Agriculture and Animal Research), end-use (Academic Research Institutes, Pharmaceutical & Biotechnology Companies, Contract Research Organizations, Hospitals and Diagnostic Centers), and region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa)

Segment Market Methodology:

The nucleic acid isolation and purification market was segmented into product, type, method, application, end-use, and regions. The demand at a segment level was deduced using a funnel method. Concepts like the TAM, SAM, SOM, etc., were put into practice to understand the demand. We at GVR deploy three methods to deduce market estimates and determine forecasts. These methods are explained below:

Market research approaches: Bottom-up

  • Demand estimation of each product across countries/regions summed up to from the total market.

  • Variable analysis for demand forecast.

  • Demand estimation via analyzing paid database, and company financials either via annual reports or paid database.

  • Primary interviews for data revalidation and insight collection.

Market research approaches: Top-down

  • Used extensively for new product forecasting or analyzing penetration levels.

  • Tool used invoice product flow and penetration models Use of regression multi-variant analysis for forecasting Involves extensive use of paid and public databases.

  • Primary interviews and vendor-based primary research for variable impact analysis.

Market research approaches: Combined

  • This is the most common method. We apply concepts from both the top-down and bottom-up approaches to arrive at a viable conclusion.

Regional Market Methodology:

The nucleic acid isolation and purification market was analyzed at a regional level. The globe was divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, keeping in focus variables like consumption patterns, export-import regulations, consumer expectations, etc. These regions were further divided into twenty-three countries, namely, the U.S.; Canada; Germany; the UK; France; Italy; Spain; Denmark; Sweden; Norway; China; Japan; India; South Korea; Australia; Thailand; Brazil; Mexico, Argentina; South Africa; Saudi Arabia, UAE; Kuwait.

All three above-mentioned market research methodologies were applied to arrive at regional-level conclusions. The regions were then summed up to form the global market.

Nucleic acid isolation and purification market companies & financials:

The nucleic acid isolation and purification market was analyzed via companies operating in the sector. Analyzing these companies and cross-referencing them to the demand equation helped us validate our assumptions and conclusions. Key market players analyzed include:

  • QIAGEN - QIAGEN is a biotechnology-based company, globally operating in over 20 countries. Key business areas of the company include assay technologies for molecular diagnostics, pharmaceutical, academic, and applied testing. The company’s product portfolio comprises a wide range of molecular testing applications. It markets over 500 products, including consumable kits and automation systems. Furthermore, molecular technologies developed by the company are being utilized by forensic technicians. The company is also involved in the isolation of genetic material from biological samples. Key customers include healthcare providers, pharmaceutical & biotechnology companies, government or industry customers, and researchers.

  • THERMO FISHER SCIENTIFIC, INC. - Thermo Fisher Scientific, Inc. is a developer, manufacturer, and provider of laboratory reagents, equipment, analytical instruments, & consumables. The company was formed by the merger of Fisher Scientific and Thermo Electron. It operates through brands such as Thermo Scientific, Applied Biosystems, Fisher Scientific, Invitrogen, and Unity Lab Services. The company’s analytical instrument segment provides equipment & instruments, consumables, as well as services, used in the production line, laboratory, and field applications. Its solutions segment provides instruments, reagents, and consumables used in disease diagnosis, medical & biological research, and novel drug & vaccines discovery.

  • ILLUMINA INC - Illumina, Inc. develops, manufactures, and commercializes integrated systems for the study of biological function and genetic variation. The company provides a range of products and services that serve genotyping, sequencing, and gene expression markets. It provides products to pharmaceutical companies, genomic research centers, clinical research organizations, academic institutions, and biotechnology companies. The company’s tools provide scientists the ability to perform genetic tests required for the extraction of medical information from advances in proteomics and genomics. The company has a strategic agreement with PerkinElmer, Inc. Verinata Health was formerly known as Artemis Health, Inc. and changed its name to Verinata Health, Inc. in April 2011.

  • DANAHER CORPORATION - Danaher designs, manufactures, and commercializes products as well as services catering to medical, professional, and commercial applications. The company operates through four segments: diagnostics, life sciences, environmental & applied solutions, and dental solutions. Danaher’s diagnostics segment offers reagents, analytical instruments, software, consumables, and services for physicians’ offices, hospitals, reference laboratories, and other critical care settings to diagnose various diseases. North America generated 38% of diagnostics share in 2016. Danaher’s facilities are in more than 60 countries across the world. In February 2011, the company acquired Beckman Coulter, Inc. to expand its business in molecular diagnostics.

  • F. HOFFMANN-LA ROCHE LTD. - F. Hoffmann-La Roche AG is involved in the development and manufacture of diagnostic & pharmaceutical products. It operates across two segments: pharmaceuticals and diagnostics. Roche sequencing (454 Life Sciences) is a subsidiary of Roche Diagnostics Corporation. In March 2007, Roche Diagnostics Corporation completed a successful purchase agreement with 454 Life Sciences, post which it has been a subsidiary of Roche. It is a privately held organization specializing in the development & commercialization of genomic sequencing & re-sequencing, metagenomics, RNA analysis, transcriptome sequencing, and DNA-targeted sequencing. The sequenced studies are used for applications in the fields of drug discovery, carcinoma studies, environmental ecology, immunogenetics, anthropology, agriculture, and paleontology. The products and systems developed by the company cater to various clients, such as drug makers, research institutes, clinical laboratories, and biotechnological companies.

  • AGILENT TECHNOLOGIES - Agilent Technologies is involved in providing analytical instruments & software for analytical scientists & clinical researchers. This company was formed in 1999 after it spun off Hewlett-Packard. It delivers products through direct sales, resellers, distributors, electronic commerce, and representatives of manufacturers. The company has offerings in pharmaceuticals, food, chemical & energy, environmental & forensics, and research segments. Its life sciences & applied market segments offer liquid & gas chromatography, mass spectrometry, spectroscopy, genomics & diagnostic consumables, services, and software. It has operations across the globe, including the Americas, Europe, Africa, and Asia Pacific. The company’s diagnostics and genomics business includes companion diagnostics, nucleic acid contract manufacturing & pathology, genomics, and reagent partnership businesses. Its genomics portfolio includes genotyping, DNA methylation profiling, identification of gene rearrangements, gene expression profiling, gene copy number determination, arrays for DNA mutation detection, NGS target enrichment, and genetic data management & interpretation support software.

  • BIO-RAD LABORATORIES, INC. - Bio-Rad Laboratories, Inc. provides tools & services for life science research, food science, and clinical diagnostics markets. The company has global operations. It offers solutions to propel scientific R&D and for the introduction of new technologies in proteomics, genomics, food safety, medical diagnostics, and drug discovery, among others. Bio-Rad’s business is segmented into life sciences and clinical diagnostics. Its life sciences segment develops, manufactures, and markets reagents, laboratory instruments, & apparatus used in clinical research, food testing regimes, & other applications. The company’s clinical diagnostics segment sells, manufactures, and supports test kits, test systems, specialized quality controls, & informatics systems that serve clinical laboratories in the diagnostics market. In April 2014, Bio-Rad Laboratories acquired GnuBio to expand its digital biology center.

  • TAKARA BIO, INC. - Takara Bio, Inc. is a global biotechnology company. It is the first company to commercialize PCR technology in Japan. The company also developed a RetroNectin reagent that is used as a global standard in gene therapy products. The company provides reagents and equipment as well as is engaged in the field of agricultural biotechnology, cell therapy, and gene therapy. The company was established as the biomedical business division of Takara Holdings, Inc., formerly known as Takara Shuzo Co., Ltd. The company has several number of distributors across the world.

  • PROMEGA CORPORATION - Promega Corporation is a global biotechnology manufacturer providing solutions for cell analysis, energy metabolism, PCR, biologics, protein-enzymes, genetics DNA markers, and analysis. Its portfolio consists of more than 4,000 products, with technical and bioinformatics support. It operates in more than 16 countries and has distribution facilities in 100 countries. Promega holds several patents in drug discovery, cellular analysis, cell biology, and bioluminescence.

Value chain-based sizing & forecasting

Supply Side Estimates

  • Company revenue estimation via referring to annual reports, investor presentations, and Hoover’s.

  • Segment revenue determination via variable analysis and penetration modeling.

  • Competitive benchmarking to identify market leaders and their collective revenue shares.

  • Forecasting via analyzing commercialization rates, pipelines, market initiatives, distribution networks, etc.

Demand side estimates

  • Identifying parent markets and ancillary markets

  • Segment penetration analysis to obtain pertinent

  • revenue/volume

  • Heuristic forecasting with the help of subject matter experts

  • Forecasting via variable analysis

Nucleic Acid Isolation And Purification Market Report Objectives:

  • Understanding market dynamics (in terms of drivers, restraints, & opportunities) in the countries.

  • Understanding trends & variables in the individual countries & their impact on growth and using analytical tools to provide high-level insights into the market dynamics and the associated growth pattern.

  • Understanding market estimates and forecasts (with the base year as 2022, historic information from 2018 to 2021, and forecast from 2023 to 2030). Regional estimates & forecasts for each category are available and are summed up to form the global market estimates.

Nucleic Acid Isolation And Purification Market Report Assumptions:

  • The report provides market value for the base year 2022 and a yearly forecast till 2030 in terms of revenue/volume or both. The market for each of the segment outlooks has been provided on region & country basis for the above-mentioned forecast period.

  • The key industry dynamics, major technological trends, and application markets are evaluated to understand their impact on the demand for the forecast period. The growth rates were estimated using correlation, regression, and time-series analysis.

  • We have used the bottom-up approach for market sizing, analyzing key regional markets, dynamics, & trends for various products and end-users. The total market has been estimated by integrating the country markets.

  • All market estimates and forecasts have been validated through primary interviews with the key industry participants.

  • Inflation has not been accounted for to estimate and forecast the market.

  • Numbers may not add up due to rounding off.

  • Europe consists of EU-8, Central & Eastern Europe, along with the Commonwealth of Independent States (CIS).

  • Asia Pacific includes South Asia, East Asia, Southeast Asia, and Oceania (Australia & New Zealand).

  • Latin America includes Central American countries and the South American continent

  • Middle East includes Western Asia (as assigned by the UN Statistics Division) and the African continent.

Primary Research

GVR strives to procure the latest and unique information for reports directly from industry experts, which gives it a competitive edge. Quality is of utmost importance to us, therefore every year we focus on increasing our experts’ panel. Primary interviews are one of the critical steps in identifying recent market trends and scenarios. This process enables us to justify and validate our market estimates and forecasts to our clients. With more than 8,000 reports in our database, we have connected with some key opinion leaders across various domains, including healthcare, technology, consumer goods, and the chemical sector. Our process starts with identifying the right platform for a particular type of report, i.e., emails, LinkedIn, seminars, or telephonic conversation, as every report is unique and requires a differentiated approach.

We send out questionnaires to different experts from various regions/ countries, which is dependent on the following factors:

  • Report/Market scope: If the market study is global, we send questionnaires to industry experts across various regions, including North America, Europe, Asia Pacific, Latin America, and MEA.

  • Market Penetration: If the market is driven by technological advancements, population density, disease prevalence, or other factors, we identify experts and send out questionnaires based on region or country dominance.

The time to start receiving responses from industry experts varies based on how niche or well-penetrated the market is. Our reports include a detailed chapter on the KoL opinion section, which helps our clients understand the perspective of experts already in the market space.

What questions do you have? Get quick response from our industry experts. Request a Free Consultation
pdf

GET A FREE SAMPLE

bck

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

cog

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member

ISO

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

great place to work icon